Journal article

A randomized clinical trial of a financial education intervention with nicotine replacement therapy (NRT) for low socio-economic status Australian smokers: a study protocol

Ryan J Courtney, Deborah Bradford, Kristy A Martire, Billie Bonevski, Ron Borland, Christopher Doran, Wayne Hall, Michael Farrell, Mohammad Siahpush, Rob Sanson-Fisher, Robert West, Richard P Mattick

ADDICTION | WILEY | Published : 2014


BACKGROUND AND AIMS: Reducing smoking prevalence among smokers from low socio-economic status (SES) is a preventative health priority. Financial stress (e.g. shortage of money or inability to pay bills) may be a major barrier to quitting smoking. This study evaluates the efficacy of a financial education and support programme coupled with pharmacotherapy at improving cessation rates at 8-month follow-up among Australian low SES smokers (people receiving a government pension or allowance). DESIGN: A two-group parallel block randomized (ratio 1 : 1) open-label clinical trial (RCT) with allocation concealment will be conducted. Allocation will be concealed to interviewers at data collection-poi..

View full abstract


Awarded by National Health and Medical Research Council (NHMRC) of Australia

Awarded by Cancer Research UK

Awarded by Economic and Social Research Council

Awarded by Medical Research Council

Funding Acknowledgements

This research is funded by a grant from the National Health and Medical Research Council (NHMRC) of Australia (grant number APP1021862). The National Drug and Alcohol Research Centre at the University of New South Wales is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund. GlaxoSmithKline is providing NRT at a reduced cost for the study. We would like to thank Emma Black, Veronica Boland, Danya Braunstein, Phillip Clare, Jaimi Iredale, Joel Tibbetts, Lauren Touyz and Emily Upton for their work on the project and the Hunter Valley Research Foundation.